Livagen

Livagen is a synthetic tetrapeptide studied for peptidase inhibition, chromatin effects, and broader aging-tissue bioregulation, with the current evidence base remaining preclinical.

Profile · 01

Overview

Livagen is a short synthetic tetrapeptide with the sequence Lys-Glu-Asp-Ala. It is discussed in the peptide bioregulator literature for effects on enzyme activity and aging-related gene expression, but it is not FDA-approved and has no published human clinical administration studies.

The source emphasizes two ideas: inhibition of enkephalin-degrading enzymes and epigenetic or chromatin-related effects in aging cells. This page summarizes the once-daily subcutaneous titration protocol from that source while keeping the evidence framing conservative.

At a Glance

Goal

Support cellular homeostasis and regenerative signaling in aging-tissue research contexts

Protocol

Suggested once-daily titration approach increasing every two weeks.

Reconstitute

Add 3.0 mL bacteriostatic water to a 20 mg vial for about 6.67 mg/mL concentration

Typical daily range

0.5-2.0 mg once daily

Start

0.5 mg daily for Weeks 1-2

Target

1.5-2.0 mg daily by Weeks 5-12

Frequency

Once daily (subcutaneous)

Cycle Length

8-12 weeks with optional extension to 16 weeks

Timing

Any consistent time; rotate injection sites

Route

Subcutaneous

Cycle

8-12 weeks on, 4 weeks off

Inject once daily subcutaneously using a relatively dilute reconstitution that keeps measurements readable. All practical dosing guidance here is extrapolated from preclinical work on enzyme inhibition, chromatin remodeling, and tissue-regeneration discussions rather than from human trials.

Dose progression

Weeks 1-2

0.5 mg · 7.5 units (0.075 mL)

Weeks 3-4

1.0 mg · 15 units (0.15 mL)

Weeks 5-6

1.5 mg · 22.5 units (0.225 mL)

Weeks 7-12

2.0 mg · 30 units (0.30 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How Livagen works.

Livagen is discussed as a short bioregulatory peptide with potent inhibition of enkephalin-degrading enzymes in human serum assays and with chromatin-related effects in aging cells. The source literature also highlights heterochromatin decondensation and ribosomal-gene reactivation as part of the proposed mechanism set.

Additional preclinical work explores organotypic liver culture effects and age-related enzyme normalization in rodents. No published human clinical dosing or efficacy trials were identified in the source material, so all protocol discussion should be treated as exploratory.

Science · 02

Effects

Observations from clinical or preclinical literature.

Preclinical literature suggests enzyme-modulating and chromatin-related effects in aging tissues

May support broader cellular-homeostasis and regenerative-signaling discussions

Rodent data suggest effects on digestive-enzyme activity and tissue maintenance

Human side-effect and efficacy data are absent

Mild injection-site irritation may occur

Long-term human safety remains uninvestigated

Science · 03

Caution

Not recommended during pregnancy or breastfeeding because safety data is absent

Use caution in autoimmune conditions due to limited immune-signaling characterization

Use caution in active cancer or proliferative disorders because gene-expression effects are not fully characterized

This remains a preclinical peptide-bioregulator entry rather than a validated clinical therapy

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Zinc

Supports enzyme systems and immune function relevant to tissue maintenance.

Vitamin D

Supports immune regulation and cellular differentiation.

B-complex vitamins

Relevant to methylation and broader epigenetic-support pathways.

Magnesium

Supports many enzymatic processes involved in cellular repair.

Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Maintain a nutrient-dense diet that supports recovery and cellular maintenance

Use regular physical activity appropriate for age and recovery status

Prioritize sleep quality and stress management because both affect regenerative signaling

Keep expectations conservative because the evidence base remains preclinical

Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

Energy and cognitive clarity - monitor for broad vitality changes cautiously
Digestive comfort and regularity - relevant to the source discussion of enzyme activity
Recovery and resilience - useful for tracking general regenerative goals
Injection-site reactions - note redness, swelling, or discomfort

Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

CBC (Complete Blood Count)

General baseline and follow-up safety context.

CMP (Comprehensive Metabolic Panel)

Assesses liver and kidney function during the protocol.

CRP (C-Reactive Protein)

Provides broad inflammatory context.

Fasting glucose and HbA1c

Useful metabolic-health baseline markers.

Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length

Vial size

Bac. water

Syringe

Vials

0 × 20 mg each…

Syringes

Bac. water

0 mL

Swabs

02 per syringe

Calculators · 02

Dose Calculator

Vial

Bac. water

Syringe

Dose

Concentration

0mg/mL

Volume per dose

0mL

…

Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

Allow vial to reach room temperature for 15–20 minutes before reconstitution.
Draw the chosen bacteriostatic water volume with a sterile syringe.
Inject slowly down vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Use within 30 days; discard any unused solution after 30 days.

Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry fully

Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue

Do not aspirate for subcutaneous injections; inject slowly and steadily

Rotate sites across the abdomen, thighs, and upper arms to reduce local irritation

Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized

Store at room temp in dry, dark conditions; minimize moisture exposure.

Reconstituted

Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.

Reference · 01

Notes

Use a new sterile insulin syringe for each injection and dispose of it safely

For very small doses, smaller-capacity insulin syringes can improve readability

No standardized human clinical administration studies were identified in the source

Document dose, site rotation, and observed effects to maintain consistency

PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.

Reference · 02

References

Biology Bulletin
Effects of Livagen and Epitalon on enkephalin-degrading enzymes from human serum.
https://link.springer.com/article/10.1023/A:1024809822681
PubMed
Effect of Livagen on digestive-enzyme activity in rats of different ages.
https://pubmed.ncbi.nlm.nih.gov/16075683/
PubMed
Functional morphology of organotypic liver culture exposed to Livagen.
https://pubmed.ncbi.nlm.nih.gov/12577697/
ResearchGate / Neuroendocrinology Letters
Peptides and ageing discussion including chromatin and gene-reactivation claims.
https://www.researchgate.net/publication/11084943_Peptides_and_Ageing
CDC
Subcutaneous injection route guidance.
https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf